Location San Diego, California, United States Regions Greater San Diego Area, West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Matteo Levisetti has extensive experience leading global clinical development for mid-size and large pharmaceutical companies. Prior to joining DNAtrix, Matteo served as Chief Medical Officer at Dauntless Pharmaceuticals where he was responsible for assets in endocrinology and oncology. Previously, Matteo directed immuno-oncology programs as
Executive Director of Clinical Development at Mirati Therapeutics. Before joining Mirati, Matteo served as Global Head & Vice President, Translational Medicine, Immunology and Inflammation at Roche Pharma Research & Early Development (pRED) and held several senior positions with Pfizer, including Global Clinical Lead. While working with Pfizer, Matteo led multiple early clinical development programs across several therapeutic areas, including endocrinology, immunology and oncology. Earlier in his career, Matteo held joint appointments as Assistant Professor in the Departments of Medicine, Pathology, and Immunology at Washington University School of Medicine. Matteo received his MD from the University of Chicago Pritzker School of Medicine, completed residency training in internal medicine at the University of Chicago Hospitals, and completed subspecialty training in endocrinology and a research fellowship in immunology with Dr. Emil R. Unanue at Washington University School of Medicine, St. Louis, Missouri.
